Table 1.
Respondents’ characteristics. ASD—autism spectrum disorder.
| Healthcare Professionals (n = 50) | |
| Male, n (%) | 3 (6%) |
| Race, n (%) | |
| White | 50 (100%) |
| Black | 0 (0%) |
| Others | 0 (0%) |
| Type of healthcare professionals | |
| Child neuropsychiatrist | 41 (82%) |
| Psychologists | 6 (12%) |
| Speech therapists | 2 (4%) |
| Professional educators | 1 (2%) |
| Years of professional experience, n (%) | |
| 1–5 | 27 (54%) |
| 6–10 | 12 (24%) |
| 11–20 | 7 (14%) |
| >20 | 4 (8%) |
| Parents (n = 45) | |
| Male, n (%) | 13 (29%) |
| Marital status, n (%) | |
| Married | 42 (94%) |
| Single | 0 (0%) |
| Divorced | 1 (2%) |
| Separeted | 2 (4%) |
| Race, n (%) | |
| White | 45 (100%) |
| Black | 0 (0%) |
| Others | 0 (0%) |
| ASD Children (n = 45) | |
| Age, years; n (%) | |
| <5 | 16 (36%) |
| 6–10 | 20 (44%) |
| 11–15 | 5 (11%) |
| 16–18 | 4 (9%) |
| Male, n (%) | 37 (82%) |
| Race, n (%) | |
| White | 45 (100%) |
| Black | 0 (0%) |
| Others | 0 (0%) |
| Severity level of ASD, n (%) | |
| 1 | 32(71%) |
| 2 | 7 (16%) |
| 3 | 6 (13%) |
| Pharmacological interventions, n (%) | |
| None | 35 (78%) |
| Antipsychotics | 7 (15%) |
| Antidepressants | 1 (2%) |
| Antiepileptics | 3 (7%) |
| Non-pharmacological interventions, n (%) | |
| None | 11 (24%) |
| Psychomotor therapy | 9 (20%) |
| Speech therapy | 11 (25%) |
| Cognitive–behavioural therapy | 17 (38%) |
| Psychotherapy | 4 (9%) |